Chairman: Kiyoshi Ando MD (Professor of Medicine, Department of Hematology and Oncology, Tokai University School of Medicine)
- "Changes in cancer treatment based on a new paradigm"
- Hideyuki Saya (Professor, Division of Gene Regulation, Institute for Advanced Medical Research,
Keio University Graduate School of Medicine)
- "An old and new cancer drug 'phenylbutyrate'"
- Masakazu Sawanobori (Chairman of Epigenetic Therapy Study Group)